Ecovyst Inc. (ECVT) FY2025 10-K Annual Report

Filed: Feb 27, 2026
Health Care
Chemicals & Allied ProductsSEC EDGAR

Ecovyst Inc. (ECVT) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 27, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

Ecovyst Inc. FY2025 10-K Analysis

Business Overview

  • Core business model: integrated provider of virgin and regenerated sulfuric acid products and related services focused on refinery customers and industrial applications
  • Divested Advanced Materials & Catalysts segment for $556M, refocusing exclusively on sulfuric acid and related services
+3 more insights

Management Discussion & Analysis

  • Revenue $723.5M in 2025, up 20.9% YoY (+$125.2M) from $598.3M in 2024, driven by higher prices (+$97.9M) and sales volume (+$27.3M)
  • Operating margin declined to 9.0% in 2025 from 14.2% in 2024; operating income $64.9M vs $85.1M, down 23.7% due to higher costs and expenses
+3 more insights

Risk Factors

  • No specific or timely risks disclosed in the provided Risk Factors section of Ecovyst Inc.'s 2026 10-K filing

Ecovyst Inc. FY2025 Key Financial Metrics
XBRL

Revenue

$724M

+2.7% YoY

Net Income

-$71M

-969.2% YoY

Gross Margin

21.8%

-676bp YoY

Operating Margin

9.0%

-496bp YoY

Net Margin

-9.8%

-889bp YoY

ROE

-11.8%

-1084bp YoY

Total Assets

$1.3B

-30.0% YoY

EPS (Diluted)

$-0.61

-916.7% YoY

Operating Cash Flow

$140M

-6.4% YoY

Source: XBRL data from Ecovyst Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Ecovyst Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.